Consolidated Statements of Cash Flows $ in Thousands	9 Months Ended
	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)
Net Cash Provided by (Used in) Operating Activities [Abstract]
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ (315,236)	$ 26,470
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Depreciation, Depletion and Amortization, Nonproduction	74,258	76,368
Amortization of contract acquisition costs	1,363	1,596
Amortization of Debt Issuance Costs	1,578	801
Imputed interest expense and fair value adjustments to contingent consideration, net	(1,496)	6,864
Accounts Receivable, Credit Loss Expense (Reversal)	2,744	1,677
(Gain) loss on disposal of assets	1,778	1,176
Asset Impairment Charges	241,544	11,083
Loss on dissolution of subsidiary	0	301
Deferred Income Tax Expense (Benefit)	38,922	(12,288)
Excess tax benefit from equity-based awards	3,921	1,807
Share-Based Payment Arrangement, Noncash Expense	15,249	16,410
(Gain) loss on foreign currency derivatives	244	552
Increase (Decrease) in Operating Capital [Abstract]
Accounts receivable	(37,497)	34,995
Prepaids and other assets	(12,959)	(1,620)
Increase (Decrease) in Accounts Payable and Accrued Liabilities	(49,122)	(8,453)
Deferred revenue and other liabilities	(23,023)	(44,508)
Net cash (used in) provided by operating activities	(57,732)	113,231
Net Cash Provided by (Used in) Investing Activities [Abstract]
Proceeds from Sale of Productive Assets	146	246
Purchases of property, plant and equipment	(36,465)	(54,722)
Net cash used in investing activities	(36,319)	(54,476)
Net Cash Provided by (Used in) Financing Activities [Abstract]
Proceeds from (Repayments of) Lines of Credit	30,000	4,000
Payments on other debt	(1,873)	(1,929)
Payments of contingent consideration and hold back payments to acquisitions	0	(37,676)
Dividends paid to shareholders	(2,847)	(24,572)
Payments of debt issuance costs	(2,635)
Payments to noncontrolling interest	(6,908)	(8,407)
Tax payments related to issuance of restricted stock units	(945)	(2,938)
Net cash (used in) provided by financing activities	14,792	(71,522)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	2,283	3,889
Increase (decrease) in cash, cash equivalents and restricted cash	(76,976)	(8,878)
Cash, cash equivalents and restricted cash, beginning of period	173,905	167,064
Cash, cash equivalents and restricted cash, end of period	96,929	158,186
Supplemental Cash Flow Information [Abstract]
Interest Paid, Excluding Capitalized Interest, Operating Activities	60,976	55,810
Income Taxes Paid	36,158	35,542
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]
Acquisition of long lived assets through finance leases	886	1,560
Acquisition of equipment through increase in accounts payable, net	$ (669)	3,534
Dividends Payable		$ 24,660